Gugliandolo, Enrico
D’amico, Ramona
Cordaro, Marika
Fusco, Roberta
Siracusa, Rosalba
Crupi, Rosalia
Impellizzeri, Daniela
Cuzzocrea, Salvatore
Di Paola, Rosanna
Article History
Received: 26 July 2018
Accepted: 3 September 2018
First Online: 14 September 2018
Ethics approval and consent to participate
: The University of Messina Review Board for the care of animals approved the research. All animal experiments observe the regulations in Italy (D.M. 116192) as well as the EU regulations (O.J. of E.C. L 358/1 12/18/1986).
: “Not applicable” in this section.
: Dr. Salvatore Cuzzocrea is a co-inventor on patent WO2013121449A8 (Epitech Group SpA) which deals with compositions and methods for the modulation of amidases capable of hydrolysing <i>N</i>-acylethanolamines applied in the therapy of inflammatory diseases. Moreover, Dr. Cuzzocrea is also a co-inventor with Epitech group on the following patents:1. EP2821,0832. MI2014A0014953. 102015000067344None of the other authors have any conflicts of interest to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.